Rimonabant

Rimonabant was a medication designed to aid weight loss and improve related health issues by blocking certain brain receptors (CB1 receptors) involved in appetite and mood regulation. By targeting these receptors, it helped reduce hunger and cravings, supporting weight management efforts. However, it was withdrawn from the market due to safety concerns, particularly related to mental health side effects like depression and anxiety. Overall, Rimonabant was an example of a drug aimed at tackling obesity through brain chemistry but was discontinued because of safety risks outweighing its benefits.